TRIMETH Drug Patent Profile

✉ Email this page to a colleague

Trimeth is a drug marketed by Alpharma Us Pharms, Naska, Avet Lifesciences, Lupin, Sun Pharm Industries, Am Regent, Hospira, Smith And Nephew, Solopak, Watson Labs, Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Teva, Bausch And Lomb, Epic Pharma Llc, Sandoz, and Somerset Theraps Llc. and is included in twenty-five NDAs.

The generic ingredient in TRIMETH is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.

US Patents:	0
Applicants:	18
NDAs:	25
Drug Prices:	Drug price information for TRIMETH
DailyMed Link:	TRIMETH at DailyMed

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	TRIMETH/SULFA	sulfamethoxazole; trimethoprim	SUSPENSION;ORAL	072289-001	May 23, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Industries	TRIMETHOPRIM	trimethoprim	TABLET;ORAL	070494-001	Jan 22, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sandoz	TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE	polymyxin b sulfate; trimethoprim sulfate	SOLUTION/DROPS;OPHTHALMIC	064211-001	Apr 13, 1998	AT	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Am Regent	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	091330-001	Mar 8, 2011		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Avet Lifesciences	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	CAPSULE;ORAL	205950-001	Nov 21, 2023	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	086577-001	Oct 19, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration